BioNet’s VacPertagen Receives the EC Approval for Pertussis Disease 

Shots:  The EC has approved VacPertagen as a booster aganist Pertussis for pts (age≥12) and for passive infant protection via maternal immunization during pregnancy     CHMP recommendation was supported by data from three clinical trials and nine supportive studies, all consistently demonstrating that VacPertagen is safe for use in teenagers, adults, and pregnant women across populations  VacPertagen is an acellular pertussis vaccine with two components, including recombinant…